logo
What Happens to Your Body When You Eat Zucchini Regularly

What Happens to Your Body When You Eat Zucchini Regularly

Yahoo4 days ago
Reviewed by Dietitian Alyssa Pike, RDNZucchini contains a variety of vitamins and nutrients, including vitamin C, beta carotene, potassium and fiber.
This humble vegetable supports digestion, eye health, hydration and heart health.
From zoodles to grilled to baked into breads and muffins, zucchini is as versatile as it is delicious.Zucchini, a versatile and delicious summer squash, has quickly risen to the top of shopping lists for eaters everywhere. Whether spiralized into zoodles or baked into bread, zucchini is a nutrient-packed vegetable that offers numerous benefits—from heart health to eye health to digestion. But what actually happens to your body when you make zucchini a regular part of your diet? Whether you're a zucchini lover or new to this vibrant green squash, keep reading to discover why this veggie deserves a permanent spot in your diet.
Zucchini is loaded with dietary fiber, especially in its skin, making it great for promoting healthy digestion. Fiber adds bulk to stool, which can improve bowel regularity and support overall gut health. 'Zucchini's fiber and water content can help soften stool and prevent constipation, while also feeding beneficial gut bacteria,' says Samantha DeVito, M.S., RD.
By including zucchini in your meals, you not only enjoy its delicious taste but also help your body meet its daily hydration needs in a natural and refreshing way. 'Zucchini is about 95% water,' says Amanda Godman, M.S., RD, CDN. 'This delicious vegetable can actually help prevent dehydration. It's a great choice especially in the warmer summer months (zucchini is actually a summer squash)!" Proper hydration is essential for maintaining energy levels, regulating body temperature, and supporting various bodily functions.
Zucchini is rich in antioxidants, which help protect your cells from damage caused by harmful free radicals. Free radicals occur through natural bodily processes but can also be compounded by exposure to smoke, pollution or an unhealthy diet. When free radicals build up, they can lead to oxidative stress—a process linked to chronic diseases. 'You'll also benefit from its antioxidants, like vitamin C and beta carotene, which help reduce inflammation and support immune health,' says Lisa Young, Ph.D., RDN. Including antioxidant-rich foods like zucchini in your diet may help strengthen your body's defenses against conditions such as heart disease and certain cancers.
This humble vegetable is a heart-healthy choice due to its potassium content and low sodium levels. Potassium helps regulate blood pressure by counteracting the effects of sodium. 'Zucchini is a heart-healthy powerhouse, rich in potassium and fiber, making it an excellent choice for supporting cardiovascular health,' says Toby Amidor, M.S., RD."'Zucchini is a heart-healthy powerhouse, rich in potassium and fiber, making it an excellent choice for supporting cardiovascular health.'"
—Toby Amidor, M.S., RD.The antioxidants in zucchini aren't just good for your internal organs; they also benefit your eyes. 'One medium zucchini contains 4,160 micrograms of lutein and zeaxanthin, carotenoids essential for eye health. Lutein and zeaxanthin accumulate in the retina, where they exert antioxidant properties to reduce eye damage from age-related macular degeneration,' says Amy Brownstein, M.S., RDN.
Zucchini offers a wide range of essential nutrients that your body needs to thrive. Here's what you can find in one small raw zucchini (about 100 grams):
Calories: 19
Carbohydrates: 3 grams
Dietary fiber: 1 gram
Total sugars: 2.5 grams
Added sugar: 0 grams
Protein: 1 gram
Total fat: 0.3 grams
Saturated fat: 0 grams
Cholesterol: 0 mg
Sodium: 8 mg
Vitamin C: 18 mg (20% Daily Value)
Vitamin B6: 0.2 mg (10% DV)
Potassium: 261 mg (6% DV)
While zucchini is considered safe for most people, there are a few precautions to keep in mind. Zucchini is part of the Cucurbitaceae family—a group of vegetables that includes squash, pumpkins and cucumbers. If you have a known allergy to cucurbit vegetables, you should avoid zucchini. Additionally, zucchini contains compounds called cucurbitacins, which can sometimes impart a bitter taste. While rare, consuming overly bitter zucchini can lead to adverse side effects like stomachaches. To avoid this, ensure your zucchini tastes fresh before cooking or eating it.
For individuals on specific medications, such as diuretics or potassium-sparing drugs, it's a good idea to consult with your health care provider before increasing your zucchini intake, as its potassium content might interact with your treatment.
Zucchini can be enjoyed in countless ways. Here are some creative ideas:
Make zoodles: Up your veggie intake by making spiralized zucchini noodles. You can top them with your favorite marinara or pesto for a delicious pasta-like meal.
Grill or roast: Brush zucchini slices with olive oil, sprinkle with your favorite herbs, and grill or roast for an easy side dish.
Bake it into bread or muffins: Add zucchini to your favorite quick bread or muffin recipe for a moist, nutrient-packed treat.
Try stuffed zucchini boats: Hollow out zucchini halves, fill with a mixture of ground meat, vegetables and cheese, and bake until tender.
Zucchini offers several health benefits, from supporting eye health to boosting heart health. Its high water and fiber content can help keep your digestive system regular, while its antioxidants can help protect your cells from oxidative stress. Plus, it's incredibly easy to incorporate into your diet, whether as a main dish, snack or side.
However, like any food, it's important to listen to your body. Monitor for any adverse reactions if you're trying zucchini for the first time, and ultimately enjoy it as part of a balanced, varied diet. With its many benefits and delicious versatility, there's no reason not to make zucchini a regular addition to your meals.
Is it OK to eat zucchini every day?
Yes, it's generally safe to eat zucchini daily, as long as it's ripe and not overly bitter. Eating zucchini regularly can provide numerous nutrients and health benefits, such as improved digestion and heart health.
Can you eat zucchini raw?
Absolutely! Zucchini can be enjoyed raw, whether sliced into salads, grated into slaws or paired with dips. Raw zucchini maintains its nutrients and provides a refreshing crunch.
What is the best way to store zucchini?
Store fresh zucchini in the refrigerator—ideally in the crisper drawer—to maintain its freshness. Try to use it within a week for the best taste and texture.
Does zucchini have a lot of carbs?
Zucchini is relatively low in carbohydrates, with only about 3 grams per small zucchini, making it an excellent choice for those who need to be mindful about their carbohydrate intake.
Why is zucchini sometimes bitter?
Bitter zucchini is often caused by high levels of cucurbitacins, naturally occurring bitter compounds found in plants such as cucumbers, pumpkins, melons and squash. To avoid bitterness, taste a small piece of zucchini raw before preparing your dish.
Read the original article on EATINGWELL
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment
Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment

Yahoo

time37 minutes ago

  • Yahoo

Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment

Edgewise Therapeutics Inc. (NASDAQ:EWTX) is one of the best up and coming stocks to invest in now. On June 26, Edgewise Therapeutics announced positive results from its sevasemten program for Becker and Duchenne muscular dystrophies. For Becker muscular dystrophy, the company reported positive data from MESA, which is an open-label extension trial that provides continued access to sevasemten for participants previously enrolled in ARCH, CANYON, GRAND CANYON, or DUNE trials. Sevasemten maintained a favorable safety profile over up to 3 years of treatment. For Duchenne muscular dystrophy, Edgewise announced encouraging topline data from its Phase 2 LYNX and FOX trials. A scientist in a lab coat using a microscope to study a cultured biopharmaceutical product. Sevasemten is an orally administered and first-in-class fast skeletal myosin inhibitor designed to protect against contraction-induced muscle damage in muscular dystrophies like Becker and Duchenne. Becker muscular dystrophy is a rare, genetic, debilitating, and degenerative neuromuscular disorder primarily affecting males, with no currently approved therapies. Duchenne muscular dystrophy is a severe degenerative muscle disorder, the most common type of muscular dystrophy, with a median life expectancy of around 30 years. Edgewise Therapeutics Inc. (NASDAQ:EWTX) is a biopharmaceutical company that discovers, develops, and commercializes therapies for the treatment of muscle disorders. While we acknowledge the potential of EWTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas

Yahoo

timean hour ago

  • Yahoo

Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott's future dual glucose-ketone sensor in the US. The collaboration aims to enhance real-time decision-making support for individuals with diabetes. The iLet Bionic Pancreas received FDA clearance in May 2023 and is distinguished as the first and only AID system that autonomously makes 100% of insulin dosing decisions. This eliminates the need for carb counting or manual insulin correction calculations for users, though they still need to be 'carb aware.' The system currently supports Abbott's FreeStyle Libre 3 Plus continuous glucose monitoring sensor, and the new agreement deepens the ongoing partnership between Beta Bionics and Abbott. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The new dual sensor is currently under development and is built on the same form factor as Abbott's FreeStyle Libre 3 Plus and will continuously monitor both glucose and ketone levels. Ketone monitoring is a crucial advancement as it can help detect early signs of diabetic ketoacidosis, which is a serious complication of diabetes. Abbott's dual glucose-ketone sensor has received FDA breakthrough device designation. Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells health care products. Beta Bionics Inc. (NASDAQ:BBNX) is a commercial-stage medical device company. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies
BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

Yahoo

time2 hours ago

  • Yahoo

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to buy now. On June 18, BrightSpring Health Services announced that its specialty pharmacy, called Onco360, has been chosen as the national pharmacy partner for several newly approved therapies. These innovative treatments target advanced cancers and rare genetic disorders. BrightSpring delivers care and clinical solutions to 400,000+ customers, clients, and patients daily across all 50 states. Onco360 will provide access, education, data, and expert support for patients suffering from advanced ovarian and lung cancers, as well as neurofibromatosis type 1. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. Onco360 has been selected as a pharmacy partner for the following specific medication therapies: GOMEKLI, which is approved for adult and pediatric patients aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas/PN not suitable for complete resection; AVMAPKI FAKZYNJA CO-PACK, which is approved for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer/LGSOC who have received prior systemic therapy; and IBTROZI, which is approved for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that operates through 2 segments: Pharmacy Solutions and Provider Services. Onco360 is a national, independent Oncology Pharmacy and clinical support services company. While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store